Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1998 2
1999 1
2001 1
2002 1
2003 2
2004 2
2008 1
2010 1
2012 1
2013 1
2015 1
2016 1
2017 2
2018 1
2019 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
New approaches for antithrombotic antiplatelet therapies.
Ulrichts H, Vanhoorelbeke K, Van De Walle G, Katsutani S, De Meyer S, Staelens S, Deckmyn H. Ulrichts H, et al. Among authors: katsutani s. Curr Med Chem. 2004 Sep;11(17):2261-3. doi: 10.2174/0929867043364630. Curr Med Chem. 2004. PMID: 15379711 Review.
Novel alternatively spliced form of beta(3)-endonexin.
Fujimoto TT, Katsutani S, Shimomura T, Fujimura K. Fujimoto TT, et al. Among authors: katsutani s. Thromb Res. 2002 Jan 1;105(1):63-70. doi: 10.1016/s0049-3848(01)00405-4. Thromb Res. 2002. PMID: 11864709
Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy.
Miyakawa Y, Katsutani S, Yano T, Nomura S, Nishiwaki K, Tomiyama Y, Higashihara M, Shirasugi Y, Nishikawa M, Ozaki K, Abe T, Kikuchi K, Kanakura Y, Fujimura K, Ikeda Y, Okamoto S. Miyakawa Y, et al. Among authors: katsutani s. Int J Hematol. 2015 Dec;102(6):654-61. doi: 10.1007/s12185-015-1887-9. Int J Hematol. 2015. PMID: 26466831 Clinical Trial.
23 results